Economic Impact Analysis: A Pocket-Sized Rapid, Multiplex PCR Diagnostic for Infection Testing for Self-Directed Healthcare

经济影响分析：用于自我指导医疗保健感染检测的袖珍快速多重 PCR 诊断

• 批准号: 10044453
• 金额: $ 6.37万
• 依托单位: LABREADY LTD
• 依托单位国家: 英国
• 项目类别: Grant for R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10044453
• 关键词: Economic; Impact; Analysis; Pocket; Sized

LabReady is developing the world's first pocket-sized, rapid, multiplex qPCR test that allow GPs, nurses, A&E, and even patients to simultaneously diagnose five different treatable infections within 30 minutes and without millions of pounds of expensive equipment, skilled technicians, and lab delays. This proposed project aims to develop the economics analysis technical model and report of how a first-of-its-kind pocket sized and rapid, multiplex qPCR diagnostic technology like MyLabReady impacts target patient populations along a self-directed healthcare pathway. As a critical milestone of the commercialization process of deploying this innovative and much needed technology into a market like the English health and social care system, this project will conduct a study into the underlying technology's cost-effectiveness and impact, including an economic model, economic costs, and outcomes cost with an appropriate comparator.

LabReady 正在开发世界上第一个袖珍、快速、多重 qPCR 测试，允许全科医生、护士、急症室甚至患者在 30 分钟内同时诊断五种不同的可治疗感染，且无需数百万英镑的昂贵设备、熟练的技术人员和实验室延误。该拟议项目旨在开发经济分析技术模型，并报告 MyLabReady 等首创的袖珍快速多重 qPCR 诊断技术如何沿着自我导向的医疗保健途径影响目标患者群体。作为将这种创新且急需的技术部署到英国医疗和社会保健系统等市场的商业化过程中的一个重要里程碑，该项目将对基础技术的成本效益和影响进行研究，包括经济模型、经济模型、成本和结果成本与适当的比较。